Sprayed Peritoneal Regional Analgesia in Appendicectomy trial - SPRAY trial

Phase 4

Completed

• Conditions: Acute appendicitis; Surgery - Surgical techniques; Anaesthesiology - Anaesthetics; Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon

• Registration Number: ACTRN12613001159741
• Lead Sponsor: The University of Auckland Department of Surgery

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-10-18
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 174

Inclusion Criteria

Acute appendicitis
Children aged 8 years and older

Exclusion Criteria

Developmental delay, neuro-muscular impairment, attention-deficit disorder, chronic pain, or psychiatric illness.
Unable to speak and read English
Partially sighted or blind
Presence of any abdominal prostheses such as a gastrostomy or ventriculo-peritoneal shunt
Allergy to bupivacaine
Consent not obtained from both the participating child and a parent or legal guardian

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Global pain scores using the Revised Faces Pain Scale (FPS-r), and a novel pain location tool developed by our unit (the Location and Level of Intensity of Postoperative Pain Score - Lolipops).[Post-operative hours 0-3, 3-6, 6-12, 12-18 and 18-24.]

Secondary Outcome Measures

Name	Time	Method
Morphine equivalent daily dose[24 hours];Proportion of patients who required opiate analgesia[24 hours];Length of hospital stay[30 days]